Parenteral plans Rs 50-cr expansion of Baddi unit

Parenteral Drugs (India) Ltd (PDIL) has chalked out a Rs 50-crore expansion plan for its Baddi unit in Himachal Pradesh.
 
"We enjoy an excise tax holiday for 10 years in Baddi. We have invested Rs 35 crore in the facility and are going to create an additional capacity with an investment of Rs 50 crore, including modernisation of our Indore units," said Anil Mittal, chief executive officer of the company.
 
PDIL started its unit in Indore to manufacture intravenous (IV) fluids in polypropylene bottles against glass bottles and further diversified into eye and ear drops and formulations (solid and liquid orals). The company set up its unit in Baddi industrial area last year for formulations; injectibles tablets and capsules.
 
"Since Indore is centrally located and freight does matter in IV fluid that is why we have decided to have our formulation unit in Baddi and IV fluid unit in Indore," he added.
 
The IV fluid is an excise free commodity. He also said that his company was gauging potential in export market.
 
"Currently 10-15 per cent of our business comes from exports but we are looking at some international-level recognition for our products," Mittal further said.

 

image
Business Standard
177 22
Business Standard

Parenteral plans Rs 50-cr expansion of Baddi unit

Shashikant Trivedi  |  New Delhi/ Bhopal 



Parenteral Drugs (India) Ltd (PDIL) has chalked out a Rs 50-crore expansion plan for its Baddi unit in Himachal Pradesh.
 
"We enjoy an excise tax holiday for 10 years in Baddi. We have invested Rs 35 crore in the facility and are going to create an additional capacity with an investment of Rs 50 crore, including modernisation of our Indore units," said Anil Mittal, chief executive officer of the company.
 
PDIL started its unit in Indore to manufacture intravenous (IV) fluids in polypropylene bottles against glass bottles and further diversified into eye and ear drops and formulations (solid and liquid orals). The company set up its unit in Baddi industrial area last year for formulations; injectibles tablets and capsules.
 
"Since Indore is centrally located and freight does matter in IV fluid that is why we have decided to have our formulation unit in Baddi and IV fluid unit in Indore," he added.
 
The IV fluid is an excise free commodity. He also said that his company was gauging potential in export market.
 
"Currently 10-15 per cent of our business comes from exports but we are looking at some international-level recognition for our products," Mittal further said.

 

RECOMMENDED FOR YOU

Parenteral plans Rs 50-cr expansion of Baddi unit

Parenteral Drugs (India) Ltd (PDIL) has chalked out a Rs 50-crore expansion plan for its Baddi unit in Himachal Pradesh.
Parenteral Drugs (India) Ltd (PDIL) has chalked out a Rs 50-crore expansion plan for its Baddi unit in Himachal Pradesh.
 
"We enjoy an excise tax holiday for 10 years in Baddi. We have invested Rs 35 crore in the facility and are going to create an additional capacity with an investment of Rs 50 crore, including modernisation of our Indore units," said Anil Mittal, chief executive officer of the company.
 
PDIL started its unit in Indore to manufacture intravenous (IV) fluids in polypropylene bottles against glass bottles and further diversified into eye and ear drops and formulations (solid and liquid orals). The company set up its unit in Baddi industrial area last year for formulations; injectibles tablets and capsules.
 
"Since Indore is centrally located and freight does matter in IV fluid that is why we have decided to have our formulation unit in Baddi and IV fluid unit in Indore," he added.
 
The IV fluid is an excise free commodity. He also said that his company was gauging potential in export market.
 
"Currently 10-15 per cent of our business comes from exports but we are looking at some international-level recognition for our products," Mittal further said.

 
image
Business Standard
177 22
Widgets Magazine

More News

Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard